Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1995 Nov;103(Suppl 8):263–268. doi: 10.1289/ehp.95103s8263

Bacterial infection as a cause of cancer.

J Parsonnet 1
PMCID: PMC1518971  PMID: 8741796

Abstract

Bacterial infections traditionally have not been considered major causes of cancer. Recently, however, bacteria have been linked to cancer by two mechanisms: induction of chronic inflammation and production of carcinogenic bacterial metabolites. The most specific example of the inflammatory mechanism of carcinogenesis is Helicobacter pylori infection. H. pylori has been epidemiologically linked to adenocarcinoma of the distal stomach by its propensity to cause lifelong inflammation. This inflammation is in turn thought to cause cancer by inducing cell proliferation and production of mutagenic free radicals and N-nitroso compounds. H. pylori is the first bacterium to be termed a definite cause of cancer in humans by the International Agency for Research on Cancer. Mutagenic bacterial metabolites are also suspected to increase risk for cancer. This model is best exemplified in colon cancer. Bile salt metabolites increase colonic cell proliferation. Exogenous compounds such as rutin may be metabolized into mutagens by resident colonic flora. Moreover, Bacteroides species can produce fecapentaenes, potent in vitro mutagens, in relatively high concentrations. In vivo data on human carcinogenesis by bacterial metabolites, however, are inconsistent. Local bacterial infections may also predispose to nonnodal lymphomas, although the mechanisms for this are unknown. Gastric lymphomas and immunoproliferative small intestinal disease have been most strongly linked to underlying bacterial infection. Because bacterial infections can be cured with antibiotics, identification of bacterial causes of malignancy could have important implications for cancer prevention.

Full text

PDF
263

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alam K., Arlow F. L., Ma C. K., Schubert T. T. Decrease in ornithine decarboxylase activity after eradication of Helicobacter pylori. Am J Gastroenterol. 1994 Jun;89(6):888–893. [PubMed] [Google Scholar]
  2. Ames B. N., Gold L. S. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science. 1990 Aug 31;249(4972):970–971. doi: 10.1126/science.2136249. [DOI] [PubMed] [Google Scholar]
  3. Banatvala N., Mayo K., Megraud F., Jennings R., Deeks J. J., Feldman R. A. The cohort effect and Helicobacter pylori. J Infect Dis. 1993 Jul;168(1):219–221. doi: 10.1093/infdis/168.1.219. [DOI] [PubMed] [Google Scholar]
  4. Baptista J., Bruce W. R., Gupta I., Krepinsky J. J., van Tassell R. L., Wilkins T. D. On distribution of different fecapentaenes, the fecal mutagens, in the human population. Cancer Lett. 1984 Apr;22(3):299–303. doi: 10.1016/0304-3835(84)90166-6. [DOI] [PubMed] [Google Scholar]
  5. Barthold S. W., Jonas A. M. Morphogenesis of early 1, 2-dimethylhydrazine-induced lesions and latent period reduction of colon carcinogenesis in mice by a variant of Citrobacter freundii. Cancer Res. 1977 Dec;37(12):4352–4360. [PubMed] [Google Scholar]
  6. Barthold S. W., Osbaldiston G. W., Jonas A. M. Dietary, bacterial, and host genetic interactions in the pathogenesis of transmissible murine colonic hyperplasia. Lab Anim Sci. 1977 Dec;27(6):938–945. [PubMed] [Google Scholar]
  7. Blaser M. J., Kobayashi K., Cover T. L., Cao P., Feurer I. D., Pérez-Pérez G. I. Helicobacter pylori infection in Japanese patients with adenocarcinoma of the stomach. Int J Cancer. 1993 Nov 11;55(5):799–802. doi: 10.1002/ijc.2910550518. [DOI] [PubMed] [Google Scholar]
  8. Borriello S. P., Drasar B. S., Tomkins A., Hill M. J. Relative carriage rates of nuclear dehydrogenating clostridia in two populations of different colorectal cancer risk. J Clin Pathol. 1983 Jan;36(1):93–95. doi: 10.1136/jcp.36.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brenes F., Ruiz B., Correa P., Hunter F., Rhamakrishnan T., Fontham E., Shi T. Y. Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol. 1993 Nov;88(11):1870–1875. [PubMed] [Google Scholar]
  10. Browne M., Healy T. M. Coexisting carcinoma and active tuberculosis of the lung: 24 patients. Ir J Med Sci. 1982 Mar;151(3):75–78. doi: 10.1007/BF02940150. [DOI] [PubMed] [Google Scholar]
  11. Butterworth B. E., Goldsworthy T. L. The role of cell proliferation in multistage carcinogenesis. Proc Soc Exp Biol Med. 1991 Nov;198(2):683–687. doi: 10.3181/00379727-198-43307. [DOI] [PubMed] [Google Scholar]
  12. Correa P., Cuello C., Duque E., Burbano L. C., Garcia F. T., Bolanos O., Brown C., Haenszel W. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst. 1976 Nov;57(5):1027–1035. doi: 10.1093/jnci/57.5.1027. [DOI] [PubMed] [Google Scholar]
  13. Correa P., Haenszel W., Cuello C., Zavala D., Fontham E., Zarama G., Tannenbaum S., Collazos T., Ruiz B. Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res. 1990 Aug 1;50(15):4737–4740. [PubMed] [Google Scholar]
  14. Davies G. R., Simmonds N. J., Stevens T. R., Sheaff M. T., Banatvala N., Laurenson I. F., Blake D. R., Rampton D. S. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut. 1994 Feb;35(2):179–185. doi: 10.1136/gut.35.2.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Deschner E. E., Ruperto J. F., Lupton J. R., Newmark H. L. Dietary butyrate (tributyrin) does not enhance AOM-induced colon tumorigenesis. Cancer Lett. 1990 Jun 30;52(1):79–82. doi: 10.1016/0304-3835(90)90080-h. [DOI] [PubMed] [Google Scholar]
  16. Di Napoli A., Petrino R., Boero M., Bellis D., Chiandussi L. Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori. J Clin Pathol. 1992 Sep;45(9):796–798. doi: 10.1136/jcp.45.9.796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Estevens J., Fidalgo P., Tendeiro T., Chagas C., Ferra A., Leitao C. N., Mira F. C. Anti-Helicobacter pylori antibodies prevalence and gastric adenocarcinoma in Portugal: report of a case-control study. Eur J Cancer Prev. 1993 Sep;2(5):377–380. doi: 10.1097/00008469-199309000-00003. [DOI] [PubMed] [Google Scholar]
  18. Fitzgerald R. H., Jr, Brewer N. S., Dahlin D. C. Squamous-cell carcinoma complicating chronic osteomyelitis. J Bone Joint Surg Am. 1976 Dec;58(8):1146–1148. [PubMed] [Google Scholar]
  19. Flance I. J. Scar cancer of the lung. JAMA. 1991 Oct 9;266(14):2003–2004. doi: 10.1001/jama.266.14.2003. [DOI] [PubMed] [Google Scholar]
  20. Forman D., Newell D. G., Fullerton F., Yarnell J. W., Stacey A. R., Wald N., Sitas F. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ. 1991 Jun 1;302(6788):1302–1305. doi: 10.1136/bmj.302.6788.1302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Forman D., Sitas F., Newell D. G., Stacey A. R., Boreham J., Peto R., Campbell T. C., Li J., Chen J. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer. 1990 Oct 15;46(4):608–611. doi: 10.1002/ijc.2910460410. [DOI] [PubMed] [Google Scholar]
  22. Forman D., Webb P., Parsonnet J. H pylori and gastric cancer. Lancet. 1994 Jan 22;343(8891):243–244. [PubMed] [Google Scholar]
  23. Fox J. G., Correa P., Taylor N. S., Thompson N., Fontham E., Janney F., Sobhan M., Ruiz B., Hunter F. High prevalence and persistence of cytotoxin-positive Helicobacter pylori strains in a population with high prevalence of atrophic gastritis. Am J Gastroenterol. 1992 Nov;87(11):1554–1560. [PubMed] [Google Scholar]
  24. Fraser A. G., Sim R., Sankey E. A., Dhillon A. P., Pounder R. E. Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment Pharmacol Ther. 1994 Apr;8(2):167–173. doi: 10.1111/j.1365-2036.1994.tb00274.x. [DOI] [PubMed] [Google Scholar]
  25. Fukao A., Komatsu S., Tsubono Y., Hisamichi S., Ohori H., Kizawa T., Ohsato N., Fujino N., Endo N., Iha M. Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study. Cancer Causes Control. 1993 Jul;4(4):307–312. doi: 10.1007/BF00051332. [DOI] [PubMed] [Google Scholar]
  26. Genta R. M., Hamner H. W., Graham D. Y. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol. 1993 Jun;24(6):577–583. doi: 10.1016/0046-8177(93)90235-9. [DOI] [PubMed] [Google Scholar]
  27. Greiner A., Marx A., Heesemann J., Leebmann J., Schmausser B., Müller-Hermelink H. K. Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab Invest. 1994 Apr;70(4):572–578. [PubMed] [Google Scholar]
  28. Guarner J., Mohar A., Parsonnet J., Halperin D. The association of Helicobacter pylori with gastric cancer and preneoplastic gastric lesions in Chiapas, Mexico. Cancer. 1993 Jan 15;71(2):297–301. doi: 10.1002/1097-0142(19930115)71:2<297::aid-cncr2820710205>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  29. Gupta I., Baptista J., Bruce W. R., Che C. T., Furrer R., Gingerich J. S., Grey A. A., Marai L., Yates P., Krepinsky J. J. Structures of fecapentaenes, the mutagens of bacterial origin isolated from human feces. Biochemistry. 1983 Jan 18;22(2):241–245. doi: 10.1021/bi00271a001. [DOI] [PubMed] [Google Scholar]
  30. Hansson L. E., Engstrand L., Nyrén O., Evans D. J., Jr, Lindgren A., Bergström R., Andersson B., Athlin L., Bendtsen O., Tracz P. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology. 1993 Oct;105(4):1098–1103. doi: 10.1016/0016-5085(93)90954-b. [DOI] [PubMed] [Google Scholar]
  31. Hennings H., Glick A. B., Greenhalgh D. A., Morgan D. L., Strickland J. E., Tennenbaum T., Yuspa S. H. Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis. Proc Soc Exp Biol Med. 1993 Jan;202(1):1–8. doi: 10.3181/00379727-202-43511a. [DOI] [PubMed] [Google Scholar]
  32. Hill M. J. Bile acids and colorectal cancer: hypothesis. Eur J Cancer Prev. 1991 Oct;1 (Suppl 2):69–74. doi: 10.1097/00008469-199110002-00012. [DOI] [PubMed] [Google Scholar]
  33. Hill M. J. Diet and the human intestinal bacterial flora. Cancer Res. 1981 Sep;41(9 Pt 2):3778–3780. [PubMed] [Google Scholar]
  34. Hirano S., Nakama R., Tamaki M., Masuda N., Oda H. Isolation and characterization of thirteen intestinal microorganisms capable of 7 alpha-dehydroxylating bile acids. Appl Environ Microbiol. 1981 Mar;41(3):737–745. doi: 10.1128/aem.41.3.737-745.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Hussell T., Isaacson P. G., Crabtree J. E., Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet. 1993 Sep 4;342(8871):571–574. doi: 10.1016/0140-6736(93)91408-e. [DOI] [PubMed] [Google Scholar]
  36. Ihamäki T., Kekki M., Sipponen P., Siurala M. The sequelae and course of chronic gastritis during a 30- to 34-year bioptic follow-up study. Scand J Gastroenterol. 1985 May;20(4):485–491. doi: 10.3109/00365528509089685. [DOI] [PubMed] [Google Scholar]
  37. Isaacson P. G. Extranodal lymphomas: the MALT concept. Verh Dtsch Ges Pathol. 1992;76:14–23. [PubMed] [Google Scholar]
  38. Kantor A. F., Hartge P., Hoover R. N., Narayana A. S., Sullivan J. W., Fraumeni J. F., Jr Urinary tract infection and risk of bladder cancer. Am J Epidemiol. 1984 Apr;119(4):510–515. doi: 10.1093/oxfordjournals.aje.a113768. [DOI] [PubMed] [Google Scholar]
  39. Khojasteh A., Haghighi P. Immunoproliferative small intestinal disease: portrait of a potentially preventable cancer from the Third World. Am J Med. 1990 Oct;89(4):483–490. doi: 10.1016/0002-9343(90)90380-v. [DOI] [PubMed] [Google Scholar]
  40. Kuipers E. J., Gracia-Casanova M., Peña A. S., Pals G., Van Kamp G., Kok A., Kurz-Pohlmann E., Pels N. F., Meuwissen S. G. Helicobacter pylori serology in patients with gastric carcinoma. Scand J Gastroenterol. 1993 May;28(5):433–437. doi: 10.3109/00365529309098245. [DOI] [PubMed] [Google Scholar]
  41. Kung I. T., Lui I. O., Loke S. L., Khin M. A., Mok C. K., Lam W. K., So S. Y. Pulmonary scar cancer. A pathologic reappraisal. Am J Surg Pathol. 1985 Jun;9(6):391–400. doi: 10.1097/00000478-198506000-00001. [DOI] [PubMed] [Google Scholar]
  42. La Vecchia C., Negri E., D'Avanzo B., Savoldelli R., Franceschi S. Genital and urinary tract diseases and bladder cancer. Cancer Res. 1991 Jan 15;51(2):629–631. [PubMed] [Google Scholar]
  43. Lin J. T., Wang J. T., Wang T. H., Wu M. S., Lee T. K., Chen C. J. Helicobacter pylori infection in a randomly selected population, healthy volunteers, and patients with gastric ulcer and gastric adenocarcinoma. A seroprevalence study in Taiwan. Scand J Gastroenterol. 1993 Dec;28(12):1067–1072. doi: 10.3109/00365529309098311. [DOI] [PubMed] [Google Scholar]
  44. Loffeld R. J., Willems I., Flendrig J. A., Arends J. W. Helicobacter pylori and gastric carcinoma. Histopathology. 1990 Dec;17(6):537–541. doi: 10.1111/j.1365-2559.1990.tb00793.x. [DOI] [PubMed] [Google Scholar]
  45. Mackowiak P. A. The normal microbial flora. N Engl J Med. 1982 Jul 8;307(2):83–93. doi: 10.1056/NEJM198207083070203. [DOI] [PubMed] [Google Scholar]
  46. Martin I. G., Aldoori M. I. Immunoproliferative small intestinal disease: Mediterranean lymphoma and alpha heavy chain disease. Br J Surg. 1994 Jan;81(1):20–24. doi: 10.1002/bjs.1800810107. [DOI] [PubMed] [Google Scholar]
  47. McIntyre A., Gibson P. R., Young G. P. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut. 1993 Mar;34(3):386–391. doi: 10.1136/gut.34.3.386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Murray W. R., Backwood A., Trotter J. M., Calman K. C., MacKay C. Faecal bile acids and clostridia in the aetiology of colorectal cancer. Br J Cancer. 1980 Jun;41(6):923–928. doi: 10.1038/bjc.1980.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Nomura A., Stemmermann G. N., Chyou P. H., Kato I., Perez-Perez G. I., Blaser M. J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991 Oct 17;325(16):1132–1136. doi: 10.1056/NEJM199110173251604. [DOI] [PubMed] [Google Scholar]
  50. Ohshima H., Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res. 1994 Mar 1;305(2):253–264. doi: 10.1016/0027-5107(94)90245-3. [DOI] [PubMed] [Google Scholar]
  51. Onuigbo W. I. Some nineteenth century ideas on links between tuberculous and cancerous diseases of the lung. Br J Dis Chest. 1975 Jul;69:207–210. doi: 10.1016/0007-0971(75)90081-9. [DOI] [PubMed] [Google Scholar]
  52. Palli D., Decarli A., Cipriani F., Sitas F., Forman D., Amadori D., Avellini C., Giacosa A., Manca P., Russo A. Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk. Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb;2(1):37–40. [PubMed] [Google Scholar]
  53. Parsonnet J., Blaser M. J., Perez-Perez G. I., Hargrett-Bean N., Tauxe R. V. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology. 1992 Jan;102(1):41–46. doi: 10.1016/0016-5085(92)91782-y. [DOI] [PubMed] [Google Scholar]
  54. Parsonnet J., Friedman G. D., Vandersteen D. P., Chang Y., Vogelman J. H., Orentreich N., Sibley R. K. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991 Oct 17;325(16):1127–1131. doi: 10.1056/NEJM199110173251603. [DOI] [PubMed] [Google Scholar]
  55. Parsonnet J., Hansen S., Rodriguez L., Gelb A. B., Warnke R. A., Jellum E., Orentreich N., Vogelman J. H., Friedman G. D. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994 May 5;330(18):1267–1271. doi: 10.1056/NEJM199405053301803. [DOI] [PubMed] [Google Scholar]
  56. Payne R. J., Nowak M. A., Blumberg B. S. Analysis of a cellular model to account for the natural history of infection by the hepatitis B virus and its role in the development of primary hepatocellular carcinoma. J Theor Biol. 1992 Nov 21;159(2):215–240. doi: 10.1016/s0022-5193(05)80703-9. [DOI] [PubMed] [Google Scholar]
  57. Potter J. D., Slattery M. L., Bostick R. M., Gapstur S. M. Colon cancer: a review of the epidemiology. Epidemiol Rev. 1993;15(2):499–545. doi: 10.1093/oxfordjournals.epirev.a036132. [DOI] [PubMed] [Google Scholar]
  58. Povey A. C., Schiffman M., Taffe B. G., Harris C. C. Laboratory and epidemiologic studies of fecapentaenes. Mutat Res. 1991 Mar-Apr;259(3-4):387–397. doi: 10.1016/0165-1218(91)90129-a. [DOI] [PubMed] [Google Scholar]
  59. Rambaud J. C., Halphen M., Galian A., Tsapis A. Immunoproliferative small intestinal disease (IPSID): relationships with alpha-chain disease and "Mediterranean" lymphomas. Springer Semin Immunopathol. 1990;12(2-3):239–250. doi: 10.1007/BF00197509. [DOI] [PubMed] [Google Scholar]
  60. Rosin M. P., Saad el Din Zaki S., Ward A. J., Anwar W. A. Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients. Mutat Res. 1994 Mar 1;305(2):283–292. doi: 10.1016/0027-5107(94)90248-8. [DOI] [PubMed] [Google Scholar]
  61. Schauer D. B., Falkow S. Attaching and effacing locus of a Citrobacter freundii biotype that causes transmissible murine colonic hyperplasia. Infect Immun. 1993 Jun;61(6):2486–2492. doi: 10.1128/iai.61.6.2486-2492.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Sierra R., Muñoz N., Peña A. S., Biemond I., van Duijn W., Lamers C. B., Teuchmann S., Hernandez S., Correa P. Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer. Cancer Epidemiol Biomarkers Prev. 1992 Sep-Oct;1(6):449–454. [PubMed] [Google Scholar]
  63. Sipponen P., Helske T., Järvinen P., Hyvärinen H., Seppälä K., Siurala M. Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985, and 1992. Gut. 1994 Sep;35(9):1167–1171. doi: 10.1136/gut.35.9.1167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Sipponen P., Kosunen T. U., Valle J., Riihelä M., Seppälä K. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol. 1992 Apr;45(4):319–323. doi: 10.1136/jcp.45.4.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Sipponen P., Riihelä M., Hyvärinen H., Seppälä K. Chronic nonatropic ('superficial') gastritis increases the risk of gastric carcinoma. A case-control study. Scand J Gastroenterol. 1994 Apr;29(4):336–340. doi: 10.3109/00365529409094845. [DOI] [PubMed] [Google Scholar]
  66. Siurala M., Varis K., Kekki M. New aspects on epidemiology, genetics, and dynamics of chronic gastritis. Front Gastrointest Res. 1980;6:148–166. doi: 10.1159/000403329. [DOI] [PubMed] [Google Scholar]
  67. Stadler J., Yeung K. S., Furrer R., Marcon N., Himal H. S., Bruce W. R. Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer. Cancer Lett. 1988 Jan;38(3):315–320. doi: 10.1016/0304-3835(88)90023-7. [DOI] [PubMed] [Google Scholar]
  68. Talley N. J., Zinsmeister A. R., Weaver A., DiMagno E. P., Carpenter H. A., Perez-Perez G. I., Blaser M. J. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst. 1991 Dec 4;83(23):1734–1739. doi: 10.1093/jnci/83.23.1734. [DOI] [PubMed] [Google Scholar]
  69. Taylor D. N., Blaser M. J. The epidemiology of Helicobacter pylori infection. Epidemiol Rev. 1991;13:42–59. doi: 10.1093/oxfordjournals.epirev.a036078. [DOI] [PubMed] [Google Scholar]
  70. Tsugane S., Kabuto M., Imai H., Gey F., Tei Y., Hanaoka T., Sugano K., Watanabe S. Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control. 1993 Jul;4(4):297–305. doi: 10.1007/BF00051331. [DOI] [PubMed] [Google Scholar]
  71. Tsujii M., Kawano S., Tsuji S., Fusamoto H., Kamada T., Sato N. Mechanism of gastric mucosal damage induced by ammonia. Gastroenterology. 1992 Jun;102(6):1881–1888. doi: 10.1016/0016-5085(92)90309-m. [DOI] [PubMed] [Google Scholar]
  72. Tsujii M., Kawano S., Tsuji S., Ito T., Nagano K., Sasaki Y., Hayashi N., Fusamoto H., Kamada T. Cell kinetics of mucosal atrophy in rat stomach induced by long-term administration of ammonia. Gastroenterology. 1993 Mar;104(3):796–801. doi: 10.1016/0016-5085(93)91015-a. [DOI] [PubMed] [Google Scholar]
  73. Tsujii M., Kawano S., Tsuji S., Nagano K., Ito T., Hayashi N., Fusamoto H., Kamada T., Tamura K. Ammonia: a possible promotor in Helicobacter pylori-related gastric carcinogenesis. Cancer Lett. 1992 Jul 31;65(1):15–18. doi: 10.1016/0304-3835(92)90207-c. [DOI] [PubMed] [Google Scholar]
  74. Turesky R. J., Markovic J., Bracco-Hammer I., Fay L. B. The effect of dose and cytochrome P450 induction on the metabolism and disposition of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx) in the rat. Carcinogenesis. 1991 Oct;12(10):1847–1855. doi: 10.1093/carcin/12.10.1847. [DOI] [PubMed] [Google Scholar]
  75. Valle J., Seppälä K., Sipponen P., Kosunen T. Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand J Gastroenterol. 1991 Oct;26(10):1057–1065. doi: 10.3109/00365529109003956. [DOI] [PubMed] [Google Scholar]
  76. Varis K. Epidemiology of gastritis. Scand J Gastroenterol Suppl. 1982;79:44–51. [PubMed] [Google Scholar]
  77. Vollmers H. P., Dämmrich J., Ribbert H., Grassel S., Debus S., Heesemannn J., Müller-Hermelink H. K. Human monoclonal antibodies from stomach carcinoma patients react with Helicobacter pylori and stimulate stomach cancer cells in vitro. Cancer. 1994 Sep 1;74(5):1525–1532. doi: 10.1002/1097-0142(19940901)74:5<1525::aid-cncr2820740506>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  78. Witz G. Active oxygen species as factors in multistage carcinogenesis. Proc Soc Exp Biol Med. 1991 Nov;198(2):675–682. doi: 10.3181/00379727-198-43306. [DOI] [PubMed] [Google Scholar]
  79. Wotherspoon A. C., Doglioni C., Diss T. C., Pan L., Moschini A., de Boni M., Isaacson P. G. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993 Sep 4;342(8871):575–577. doi: 10.1016/0140-6736(93)91409-f. [DOI] [PubMed] [Google Scholar]
  80. Wotherspoon A. C., Ortiz-Hidalgo C., Falzon M. R., Isaacson P. G. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991 Nov 9;338(8776):1175–1176. doi: 10.1016/0140-6736(91)92035-z. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES